(Q53670261)

17 May 2018

title

Development of a synthetic consensus sequence scrambled antigen HIV-1 vaccine designed for global use. (English)

1 reference

17 May 2018

1 reference

7

1 reference

17 May 2018

author name string

Scott A Thomson

1

1 reference

17 May 2018

Angel B Jaramillo

2

1 reference

17 May 2018

Maryanne Shoobridge

3

1 reference

17 May 2018

Kerrie J Dunstan

4

1 reference

17 May 2018

Beth Everett

5

1 reference

17 May 2018

Charani Ranasinghe

6

1 reference

17 May 2018

Ke Gao

8

1 reference

17 May 2018

Jill Medveckzy

9

1 reference

17 May 2018

Rosemary A Ffrench

10

1 reference

17 May 2018

Ian A Ramshaw

11

1 reference

17 May 2018

language of work or name

English

0 references

publication date

1 September 2005

1 reference

17 May 2018

published in

Vaccine

1 reference

17 May 2018

volume

23

1 reference

17 May 2018

issue

38

1 reference

17 May 2018

page(s)

4647-4657

1 reference

17 May 2018

The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

Diversity considerations in HIV-1 vaccine selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

HIV-1 diversity and vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

7 January 2021

Vaccines. Monkey puzzles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

Development of a DNA-MVA/HIVA vaccine for Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.045

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.04.045

1 reference

17 May 2018

PubMed ID

15964105

1 reference

17 May 2018